Vyome Holdings, Inc
HIND- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001427570
No open-market purchases or sales by Vyome Holdings, Inc insiders were filed in the last 90 days; 12 institutions reported holding it in 13F filings for Q2 2026, worth $296.5K in total; no superinvestor holds it.
13F holders, Q3 2022
Institutional positions in Vyome Holdings, Inc as of Sep 30, 2022. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 23
- +4 vs. Q2 2022
- Shares held
- 795.5K
- −498.7K (−38.5%) vs. Q2 2022
- Total value
- $237.0K
- −$507.0K (−68.1%) vs. Q2 2022
- New holders
- 6
- 4 more added
- Sold out
- 2
- 6 more reduced
Compare with Q2 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting HIND on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 12 | $296.5K |
| Q1 2026 | 9 | $198.3K |
| Q4 2025 | 8 | $322.3K |
| Q3 2025 | 5 | $125.4K |
| Q2 2025 | 0 | $0 |
| Q1 2025 | 1 | $1 |
| Q4 2024 | 1 | $13 |
| Q3 2024 | 2 | $24 |
| Q2 2024 | 16 | $73.3K |
| Q1 2024 | 18 | $49.1K |
| Q4 2023 | 15 | $108.3K |
| Q3 2023 | 17 | $134.7K |
| Q2 2023 | 11 | $153.5K |
| Q1 2023 | 13 | $370.3K |
| Q4 2022 | 10 | $12.2K |
| Q3 2022 | 23 | $237.0K |
| Q2 2022 | 19 | $744.0K |
| Q1 2022 | 17 | $1.45M |
| Q4 2021 | 15 | $1.91M |
| Q3 2021 | 18 | $1.90M |
| Q2 2021 | 15 | $5.23M |
| Q1 2021 | 0 | $0 |
Institutions, Q3 2022
Shares, value and share of portfolio for each institution holding Vyome Holdings, Inc; share changes are against Q2 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Geode Capital Management, LLC | 306,611 | $92.0K | 0.00% | +8,748+2.9% | Added |
| Vanguard Group Inc | 118,607 | $36.0K | 0.00% | −385,008−76.4% | Reduced |
| HRT Financial LP | 55,887 | $16.0K | 0.00% | +55,887 | New |
| Jane Street Group, LLC | 52,180 | $16.0K | 0.00% | +52,180 | New |
| Price T Rowe Associates Inc | 36,100 | $11.0K | 0.00% | −134,800−78.9% | Reduced |
| Renaissance Technologies LLC | 32,883 | $10.0K | 0.00% | −11,814−26.4% | Reduced |
| Northern Trust Corp | 33,426 | $10.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 32,235 | $10.0K | 0.00% | +29,979+1,328.9% | Added |
| Susquehanna Fundamental Investments, LLC | 30,200 | $9.00K | 0.00% | +30,200 | New |
| State Street Corp | 20,700 | $6.00K | 0.00% | 00.0% | Unchanged |
| Two Sigma Securities, LLC | 20,294 | $6.00K | 0.00% | +868+4.5% | Added |
| Goldman Sachs Group Inc | 14,343 | $4.00K | 0.00% | +14,343 | New |
| Ergoteles LLC | 13,958 | $4.00K | 0.00% | +13,958 | New |
| Virtu Financial LLC | 10,791 | $3.00K | 0.00% | −14,789−57.8% | Reduced |
| Millennium Management LLC | 10,702 | $3.00K | 0.00% | +10,702 | New |
| Advisor Group Holdings, Inc. | 3,959 | $1.00K | 0.00% | 00.0% | Unchanged |
| UBS Group AG | 1,290 | $0 | 0.00% | −4,724−78.6% | Reduced |
| BlackRock Inc. | 897 | $0 | 0.00% | 00.0% | Unchanged |
| Wells Fargo & Company | 148 | $0 | 0.00% | −11−6.9% | Reduced |
| Morgan Stanley | 80 | $0 | 0.00% | +76+1,900.0% | Added |
| Group One Trading, L.P. | 112 | $0 | 0.00% | 00.0% | Unchanged |
| Banque Cantonale Vaudoise | 1 | $0 | 0.00% | 00.0% | Unchanged |
| Transamerica Financial Advisors, Inc. | 75 | – | – | 00.0% | Unchanged |
| Armistice Capital, LLC | 0 | $0 | 0.00% | −142,991−100.0% | Sold out |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −21,546−100.0% | Sold out |